Smisson-Cartledge Biomedical Presents Infusion System At In3 Medical Device Summit
San Francisco, CA & Atlanta, GA - Smisson-Cartledge Biomedical, LLC (SCB), attendees of the recent In3 Medical Device Summit in San Francisco, California, has received the U.S. Food and Drug Administration (FDA) market clearance of their ThermaCor 1200 thermal infusion system — the first full range, portable normothermic infusion system. SCB was funded in part by the U.S. Military to bring this state-of-the-art, life-saving technology to our wounded soldiers and civilians suffering traumatic injuries or requiring extensive surgeries.
The ThermaCor 1200 Infusion System is a revolutionary full range, portable infusion system that is capable of delivering flow rates from 10 mL/Hour up to 1200 mL/Minute. This extensive delivery range can actually eliminate the need for several pumps making the ThermaCor 1200 a truly All-in-One infusion system. This advanced thermal system incorporates a proprietary, super-efficient Waveform Heat Exchanger that enables the rapid warming of fluids to body temperature in an extremely compact, easy-to-use device. SCB has also integrated a proprietary ShurGard air trapping and elimination system that enables the system to run virtually continuously.
"We are convinced that the ThermaCor 1200 Infusion System represents a breakthrough in rapid setup and safe delivery of a high flow of warm fluids (blood) to patients in need through a compact, easy-to-use device," commented David Field, President and CEO of SCB. "Our system, with its proprietary and unique one-latch loading, makes setup (<15 seconds) dramatically easier and faster than any similar device which is critical in the trauma and OR environments."
Dr. Richard Cartledge, Cardiovascular Surgeon and Co-Founder of the ThermaCor 1200, states that, "This exciting technology platform will enable more clinicians to safely and efficiently deliver normothermic (body temperature) fluids wherever and whenever it is needed." "While our first device introduction is focused on controlled warming of fluids, our technology platform extends to rapid inline cooling of fluids for other applications such as heart attack and stroke patients," added Dr. Hugh Smisson III, Neurosurgeon and Co-Founder.
SOURCE: Smisson-Cartledge Biomedical, LLC